Central Role of IL-23 and IL-17 Producing Eosinophils as Immunomodulatory Effector Cells in Acute Pulmonary Aspergillosis and Allergic Asthma

PLoS Pathogens

Volumn 13, Issue 1, 2017, Pages

  Guerra, Evelyn Santos ^a   Lee, Chrono K ^a   Specht, Charles A ^a   Yadav, Bhawna ^a   Huang, Haibin ^a   Akalin, Ali ^a   Huh, Jun R ^a   Mueller, Christian ^a   Levitz, Stuart M ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD45 ANTIGEN; GLYCOPROTEIN P 15095; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 23P19;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPERGILLUS FUMIGATUS; BRONCHOALVEOLAR LAVAGE FLUID; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DISEASE PREDISPOSITION; EOSINOPHIL; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; LUNG ALVEOLUS MACROPHAGE; LUNG ASPERGILLOSIS; LUNG LAVAGE; MACROPHAGE; MONOCYTE; MORTALITY RATE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; ANIMAL; ASTHMA; BAGG ALBINO MOUSE; C57BL MOUSE; CELL SEPARATION; DISEASE MODEL; HYPERSENSITIVITY; IMMUNOLOGY;

ANIMALS; ASPERGILLUS FUMIGATUS; ASTHMA; CELL SEPARATION; DISEASE MODELS, ANIMAL; EOSINOPHILS; FLOW CYTOMETRY; HYPERSENSITIVITY; INTERLEUKIN-17; INTERLEUKIN-23; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; PULMONARY ASPERGILLOSIS;

EID: 85010977551     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1006175     Document Type: Article

References (68)

1. Kwon-Chung KJ, Sugui JA, (2013) Aspergillus fumigatus—What Makes the Species a Ubiquitous Human Fungal Pathogen?PLoS Pathogens9: e1003743. doi: 10.1371/journal.ppat.100374324348239
2. Park SJ, Mehrad B, (2009) Innate Immunity to Aspergillus Species. Clinical Microbiology Reviews22: 535–551. doi: 10.1128/CMR.00014-0919822887
3. Latge JP, (1999) Aspergillus fumigatus and Aspergillosis. Clinical Microbiology Reviews12: 310–350. 10194462
4. Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, et al. (2012) Hidden killers: human fungal infections. Science translational medicine4: 165rv113.
5. Armstead J, Morris J, Denning DW, (2014) Multi-country estimate of different manifestations of aspergillosis in cystic fibrosis. PLoS ONE9: e98502. doi: 10.1371/journal.pone.009850224914809
6. Denning DW, Pleuvry A, Cole DC, (2013) Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults. Medical Mycology51: 361–370. doi: 10.3109/13693786.2012.73831223210682
7. Denning DW, (2006) The link between fungi and severe asthma: a summary of the evidence. European Respiratory Journal27: 615–626. doi: 10.1183/09031936.06.0007470516507864
8. Knutsen AP, Bush RK, Demain JG, Denning DW, Dixit A, et al. (2012) Fungi and allergic lower respiratory tract diseases. Journal of Allergy and Clinical Immunology129: 280–291. doi: 10.1016/j.jaci.2011.12.97022284927
9. O'Dea EM, Amarsaikhan N, Li H, Downey J, Steele E, et al. (2014) Eosinophils are recruited in response to chitin exposure and enhance Th2-mediated immune pathology in Aspergillus fumigatus infection. Infection and immunity82: 3199–3205. doi: 10.1128/IAI.01990-1424842927
10. Lilly LM, Scopel M, Nelson MP, Burg AR, Dunaway CW, et al. (2014) Eosinophil Deficiency Compromises Lung Defense against Aspergillus fumigatus. Infection and Immunity82: 1315–1325. doi: 10.1128/IAI.01172-1324379296
11. Iwakura Y, (2006) The IL-23/IL-17 axis in inflammation. Journal of Clinical Investigation116: 1218–1222. doi: 10.1172/JCI2850816670765
12. Iwakura Y, Ishigame H, Saijo S, Nakae S, (2011) Functional Specialization of Interleukin-17 Family Members. Immunity34: 149–162. doi: 10.1016/j.immuni.2011.02.01221349428
13. Vinh DC, (2011) Insights into human antifungal immunity from primary immunodeficiencies. The Lancet Infectious Diseases11: 780–792. doi: 10.1016/S1473-3099(11)70217-121958581
14. Werner JL, Metz AE, Horn D, Schoeb TR, Hewitt MM, et al. (2009) Requisite Role for the Dectin-1 -Glucan Receptor in Pulmonary Defense against Aspergillus fumigatus. The Journal of Immunology182: 4938–4946. doi: 10.4049/jimmunol.080425019342673
15. Zenobia C, Hajishengallis G, (2015) Basic biology and role of interleukin-17 in immunity and inflammation. Periondotology 200069: 142–159.
16. Murdock BJ, Falkowski NR, Shreiner AB, Sadighi Akha AA, McDonald RA, et al. (2012) Interleukin-17 Drives Pulmonary Eosinophilia following Repeated Exposure to Aspergillus fumigatus Conidia. Infection and Immunity80: 1424–1436. doi: 10.1128/IAI.05529-1122252873
17. Lambrecht BN, Hammad H, (2014) The immunology of asthma. Nature Immunology16: 45–56.
18. Underhill DM, Pearlman E, (2015) Immune Interactions with Pathogenic and Commensal Fungi: A Two-Way Street. Immunity43: 845–858. doi: 10.1016/j.immuni.2015.10.02326588778
19. Taylor PR, Roy S, Leal SM, Jr.Sun Y, Howell SJ, et al. (2014) Activation of neutrophils by autocrine IL-17A-IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORgammat and dectin-2. Nature Immunology15: 143–151. doi: 10.1038/ni.279724362892
20. Song C, Luo L, Lei Z, Li B, Liang Z, et al. (2008) IL-17-Producing Alveolar Macrophages Mediate Allergic Lung Inflammation Related to Asthma. The Journal of Immunology181: 6117–6124. 18941201
21. Lee JJ, Jacobsen EA, Ochkur SI, McGarry MP, Condjella RM, et al. (2012) Human versus mouse eosinophils: "That which we call an eosinophil, by any other name would stain as red". Journal of Allergy and Clinical Immunology130: 572–584. doi: 10.1016/j.jaci.2012.07.02522935586
22. Stevens WW, Kim TS, Pujanauski LM, Hao X, Braciale TJ, (2007) Detection and quantitation of eosinophils in the murine respiratory tract by flow cytometry. Journal of Immunological Methods327: 63–74. doi: 10.1016/j.jim.2007.07.01117716680
23. Vermaelen K, Pauwels R, (2004) Accurate and simple discrimination of mouse pulmonary dendritic cell and macrophage populations by flow cytometry: Methodology and new insights. Cytometry61A: 170–177.
24. Weil GJ, Chused TM, (1981) Eosinophil Autofluorescence and its Use in Isolation and Analysis of Human Eosinophils Using Flow Microfluorometry. Blood57: 1099–1104. 7225570
25. Mesnil C, Raulier S, Paulissen G, Xiao X, Birrell MA, et al. (2016) Lung-resident eosinophils represent a distinct regulatory eosinophil subset. The Journal of clinical investigation.
26. Jhingran A, Mar KB, Kumasaka DK, Knoblaugh SE, Ngo LY, et al. (2012) Tracing Conidial Fate and Measuring Host Cell Antifungal Activity Using a Reporter of Microbial Viability in the Lung. Cell Reports2: 1762–1773. doi: 10.1016/j.celrep.2012.10.02623200858
27. Cua DJ, Tato CM, (2010) Innate IL-17-producing cells: the sentinels of the immune system. Nature Reviews Immunology: 1–12.
28. Gordon S, Taylor PR, (2005) Monocyte and macrophage heterogeneity. Nature Reviews Immunology5: 953–964. doi: 10.1038/nri173316322748
29. Espinosa V, Jhingran A, Dutta O, Kasahara S, Donnelly R, et al. (2014) Inflammatory Monocytes Orchestrate Innate Antifungal Immunity in the Lung. PLoS Pathogens10: e1003940. doi: 10.1371/journal.ppat.100394024586155
30. Fuller KK, Chen S, Loros JJ, Dunlap JC, (2015) Development of the CRISPR/Cas9 System for Targeted Gene Disruption in Aspergillus fumigatus. Eukaryotic Cell14: 1073–1080. doi: 10.1128/EC.00107-1526318395
31. Pasqualotto AC, (2009) Differences in pathogenicity and clinical syndromes due to Aspergillus fumigatus and Aspergillus flavus. Medical Mycology47: S261–S270. doi: 10.1080/1369378080224770218654921
32. Rizzetto L, Giovannini G, Bromley M, Bowyer P, Romani L, et al. (2013) Strain Dependent Variation of Immune Responses to A. fumigatus: Definition of Pathogenic Species. PLoS ONE8: e56651. doi: 10.1371/journal.pone.005665123441211
33. Scharf DH, Heinekamp T, Remme N, Hortschansky P, Brakhage AA, et al. (2011) Biosynthesis and function of gliotoxin in Aspergillus fumigatus. Applied Microbiology and Biotechnology93: 467–472. doi: 10.1007/s00253-011-3689-122094977
34. Wiederhold NP, Najvar LK, Vallor AC, Kirkpatrick WR, Bocanegra R, et al. (2008) Assessment of Serum (1–3)- beta-D-Glucan Concentration as a Measure of Disease Burden in a Murine Model of Invasive Pulmonary Aspergillosis. Antimicrobial Agents and Chemotherapy52: 1176–1178. doi: 10.1128/AAC.01425-0718160526
35. Chesné J, Braza F, Mahay G, Brouard S, Aronica M, et al. (2014) IL-17 in Severe Asthma. Where Do We Stand?American Journal of Respiratory and Critical Care Medicine190: 1094–1101. doi: 10.1164/rccm.201405-0859PP25162311
36. Mueller C, Keeler A, Braag S, Menz T, Tang Q, et al. (2009) Modulation of Exaggerated-IgE Allergic Responses by Gene Transfer-mediated Antagonism of IL-13 and IL-17e. Molecular Therapy18: 511–518. doi: 10.1038/mt.2009.26419935781
37. Nials AT, Uddin S, (2008) Mouse models of allergic asthma: acute and chronic allergen challenge. Disease Models and Mechanisms1: 213–220. doi: 10.1242/dmm.00032319093027
38. Sugawara R, Lee E-J, Jang MS, Jeun E-J, Hong C-P, et al. (2016) Small intestinal eosinophils regulate Th17 cells by producing IL-1 receptor antagonist. The Journal of Experimental Medicine213: 555–567. doi: 10.1084/jem.2014138826951334
39. Spencer LA, Weller PF, (2010) Eosinophils and Th2 immunity: contemporary insights. Immunology and Cell Biology88: 250–256. doi: 10.1038/icb.2009.11520065995
40. Rosenberg HF, Dyer KD, Foster PS, (2013) Eosinophils: changing perspectives in health and disease. Nature reviews Immunology13: 9–22. doi: 10.1038/nri334123154224
41. Qu N, Xu M, Mizoguchi I, Furusawa J, Kaneko K, et al. (2013) Pivotal roles of T-helper 17-related cytokines, IL-17, IL-22, and IL-23, in inflammatory diseases. Clinical & developmental immunology2013: 968549.
42. Molet S, Hamid Q, Davoineb F, Nutku E, Tahaa R, et al. (2001) IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. Journal of Allergy and Clinical Immunology108: 430–438. doi: 10.1067/mai.2001.11792911544464
43. Shimura E, Shibui A, Narushima S, Nambu A, Yamaguchi S, et al. (2014) Potential role of myeloid cell/eosinophil-derived IL-17 in LPS-induced endotoxin shock. Biochemical and Biophysical Research Communications453: 1–6. doi: 10.1016/j.bbrc.2014.09.00425204502
44. Kobayashi T, Kouzaki H, Kita H, (2010) Human Eosinophils Recognize Endogenous Danger Signal Crystalline Uric Acid and Produce Proinflammatory Cytokines Mediated by Autocrine ATP. The Journal of Immunology184: 6350–6358. doi: 10.4049/jimmunol.090267320483787
45. Gaffen SL, Jain R, Garg AV, Cua DJ, (2014) The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat Rev Immunol14: 585–600. doi: 10.1038/nri370725145755
46. Teng MWL, Bowman EP, McElwee JJ, Smyth MJ, Casanova J-L, et al. (2015) IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases. Nat Med21: 719–729. doi: 10.1038/nm.389526121196
47. Jacobsen EA, Lee NA, Lee JJ, (2014) Re-defining the unique roles for eosinophils in allergic respiratory inflammation. Clinical & Experimental Allergy44: 1119–1136.
48. Aujla SJ, Alcorn JF, (2011) Th17 cells in asthma and inflammation. Biochimica et Biophysica Acta1810: 1066–1079. doi: 10.1016/j.bbagen.2011.02.00221315804
49. Chesné J, Braza F, Chadeuf G, Mahay G, Cheminant M-A, et al. (2015) Prime role of IL-17A in neutrophilia and airway smooth muscle contraction in a house dust mite-induced allergic asthma model. Journal of Allergy and Clinical Immunology135: 1643–1645.e1645. doi: 10.1016/j.jaci.2014.12.187225649077
50. Ono N, Kusunoki T, Ikeda K, (2012) Relationships between IL-17A and macrophages or MUC5AC in eosinophilic chronic rhinosinusitis and proposed pathological significance. Allergy & Rhinology3: 50–54.
51. Shimizu S, Kouzaki H, Ogawa T, Takezawa K, Tojima I, et al. (2014) Eosinophil-epithelial cell interactions stimulate the production of MUC5AC mucin and profibrotic cytokines involved in airway tissue remodeling. American journal of rhinology & allergy28: 103–109.
52. Furuta GT, Atkins FD, Lee NA, Lee JJ, (2014) Changing roles of eosinophils in health and disease. Annals of Allergy, Asthma & Immunology113: 3–8.
53. Skloot GS, (2016) Asthma phenotypes and endotypes. Current Opinion in Pulmonary Medicine22: 3–9. doi: 10.1097/MCP.000000000000022526574717
54. Pakhale S, Mulpuru S, Boyd M, (2011) Optimal Management of Severe/Refractory Asthma. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine5: 37–47. doi: 10.4137/CCRPM.S553521912491
55. Simpson JL, Scott R, Boyle M, Gibson PG, (2006) Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology11: 54–61. doi: 10.1111/j.1440-1843.2006.00784.x16423202
56. Travers J, Rothenberg ME, (2015) Eosinophils in mucosal immune responses. Mucosal Immunology8: 464–475. doi: 10.1038/mi.2015.225807184
57. Levitz SM, Selsted ME, Ganz T, Lehrer RI, Diamond RD, (1986) In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages. The Journal of infectious diseases154: 483–489. 3525696
58. Casadevall A, Pirofski LA, (2003) The damage-response framework of microbial pathogenesis. Nature reviews Microbiology1: 17–24. doi: 10.1038/nrmicro73215040176
59. Loures FV, Rohm M, Lee CK, Santos E, Wang JP, et al. (2015) Recognition of Aspergillus fumigatus hyphae by human plasmacytoid dendritic cells is mediated by dectin-2 and results in formation of extracellular traps. PLoS Pathogens11: e1004643. doi: 10.1371/journal.ppat.100464325659141
60. Ramirez-Ortiz ZG, Lee CK, Wang JP, Boon L, Specht CA, et al. (2011) A nonredundant role for plasmacytoid dendritic cells in host defense against the human fungal pathogen Aspergillus fumigatus. Cell host & microbe9: 415–424.
61. Shepardson KM, Jhingran A, Caffrey A, Obar JJ, Suratt BT, et al. (2014) Myeloid Derived Hypoxia Inducible Factor 1-alpha Is Required for Protection against Pulmonary Aspergillus fumigatus Infection. PLoS Pathogens10: e1004378. doi: 10.1371/journal.ppat.100437825255025
62. Wang JP, Lee CK, Akalin A, Finberg RW, Levitz SM, (2011) Contributions of the MyD88-dependent receptors IL-18R, IL-1R, and TLR9 to host defenses following pulmonary challenge with Cryptococcus neoformans. PloS one6: e26232. doi: 10.1371/journal.pone.002623222039448
63. Specht CA, Lee CK, Huang H, Tipper DJ, Shen ZT, et al. (2015) Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts. mBio6: e01905–01915. doi: 10.1128/mBio.01905-1526695631
64. Dyer KD, Moser JM, Czapiga M, Siegel SJ, Percopo CM, et al. (2008) Functionally competent eosinophils differentiated ex vivo in high purity from normal mouse bone marrow. Journal of immunology181: 4004–4009.
65. Jhingran A, Kasahara S, Shepardson KM, Junecko BAF, Heung LJ, et al. (2015) Compartment-Specific and Sequential Role of MyD88 and CARD9 in Chemokine Induction and Innate Defense during Respiratory Fungal Infection. PLoS Pathogens11: e1004589. doi: 10.1371/journal.ppat.100458925621893
66. Hufford MM, Kim TS, Sun J, Braciale TJ, (2011) Antiviral CD8+ T cell effector activities in situ are regulated by target cell type. Journal of Experimental Medicine208: 167–180. doi: 10.1084/jem.2010185021187318
67. Wiesner DL, Specht CA, Lee CK, Smith KD, Mukaremera L, et al. (2015) Chitin Recognition via Chitotriosidase Promotes Pathologic Type-2 Helper T Cell Responses to Cryptococcal Infection. PLoS Pathogens11: e1004701. doi: 10.1371/journal.ppat.100470125764512
68. Herzenberg LA, Tung J, Moore WA, Herzenberg LA, Parks DR, (2006) Interpreting flow cytometry data: a guide for the perplexed. Nature Immunology7: 681–685. doi: 10.1038/ni0706-68116785881